Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Person writing with pen

Translating the promise of 5HT4 receptor agonists for the treatment of depression.

Murphy SE. et al, (2021), Psychol Med, 51, 1111 - 1120

An exploration of the pro-cognitive potential of the 5-HT4 agonist, prucalopride, in the healthy human brain

De Cates A. et al, (2021), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 44, S43 - S44

Gender equality in academic publishing: action from the BJPsych.

Upthegrove R. et al, (2020), Br J Psychiatry, 1 - 3

Adjunctive benzodiazepines in depression: A clinical dilemma with no recent answers from research

De Cates AN. and De Giorgi R., (2020), BJPsych Advances, 26, 321 - 326

Adjunctive benzodiazepines in depression: A clinical dilemma with no recent answers from research

De Cates AN. and De Giorgi R., (2020), BJPsych Advances, 26, 321 - 326

Use of paliperidone palmitate long-acting injection in dual diagnosis patients

De Cates A. et al, (2012), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 22, S321 - S322